Show simple item record

dc.contributor.authorTroøyen, Susanne Hansen
dc.contributor.authorJacobsen, Elisabeth Egholm
dc.date.accessioned2023-02-15T09:58:50Z
dc.date.available2023-02-15T09:58:50Z
dc.date.created2023-01-05T13:06:07Z
dc.date.issued2022
dc.identifier.citationCatalysts. 2022, 12 (12), .en_US
dc.identifier.issn2073-4344
dc.identifier.urihttps://hdl.handle.net/11250/3050994
dc.description.abstractThe β-blocker (S)-betaxolol has been synthesized in 99% enantiomeric excess (ee) from the commercially available precursor 4-(2-hydroxyethyl)phenol. The racemic chlorohydrin 1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol was esterified with vinyl acetate catalyzed by lipase B from Candida antarctica, which gave the R-chlorhydrin (R)-1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol in 99% ee with 38% yield. The enantiomeric excess of the R-chlorohydrin was retained in an amination reaction with isopropylamine in methanol to yield (S)-betaxolol in 99% ee and with 9% overall yield. We are under way to improve the yield.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleChemo-Enzymatic Synthesis of Enantiopure β-Antagonist (S)-Betaxololen_US
dc.title.alternativeChemo-Enzymatic Synthesis of Enantiopure β-Antagonist (S)-Betaxololen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber0en_US
dc.source.volume12en_US
dc.source.journalCatalystsen_US
dc.source.issue12en_US
dc.identifier.doi10.3390/catal12121645
dc.identifier.cristin2101293
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal